Mechanisms of Ischaemic Strokes and Transient Ischaemic Attacks Despite Oral Anticoagulation in Patients With Atrial Fibrillation
Loading...
Files
Size: 161.15 KB, File format: Adobe PDF
Date
Authors
Mahawish, KM
Feigin, V
Krishnamurthi, R
White, HD
Supervisor
Item type
Degree name
Journal Title
Journal ISSN
Volume Title
Publisher
Pasifika Medical Association Group
Abstract
Aims: The aim of this article was to characterise the mechanisms underlying “breakthrough” ischaemic stroke (IS) or transient ischaemic attack (TIA) despite oral anticoagulation in patients with atrial fibrillation (AF).
Methods: We conducted a cross-sectional analysis of adults with non-valvular AF who experienced IS/TIA in the fifth Auckland Regional Community Stroke Study (ARCOS V: September 2020 to August 2021). Using clinical records, we collected data on demographics, comorbidities and peri-event anticoagulant dosing and intake. Anticoagulant adherence in the months preceding IS/TIA was categorised as good control if proportion of days covered (PDC) ≥80% for direct oral anticoagulant users or time in therapeutic range (TTR) ≥70% for warfarin users. IS/TIA mechanism was adjudicated using standardised criteria and classified as cardioembolic or non-cardioembolic, and patient characteristics were compared.
Results: Among 179 patients (76/179 [43%] female), 138/179 events (77%) were adjudicated as cardioembolic, while the remainder were attributed to competing mechanisms. Compared with non-cardioembolic events, cardioembolic aetiology was associated with younger median age (72 vs 81 years), lower proportions with good anticoagulant control (87/138 [63%] vs 34/41 [83%], p=0.017) and higher rates of peri-event missed or under-dosing (90/138 [65%] vs 18/41 [44%], p=0.014). In multivariable analysis, good control was independently associated with higher odds of a non-cardioembolic mechanism (adjusted odds ratio 3.67 [95% confidence interval 1.35–9.99], p=0.011).
Conclusion: Most breakthrough IS/TIA events on oral anticoagulation were either associated with anticoagulant under-exposure (in patients with a cardioembolic aetiology) or a competing mechanism rather than anticoagulant failure. These findings highlight the importance of careful assessment to inform appropriate secondary prevention strategies.
Description
Keywords
11 Medical and Health Sciences, General & Internal Medicine, 32 Biomedical and clinical sciences, 42 Health sciences
Source
New Zealand Medical Journal, ISSN: 0028-8446 (Print); 1175-8716 (Online), Pasifika Medical Association Group, 139(1636), 44-51. doi: 10.26635/6965.7380
Rights statement
Open Access. The New Zealand Medical Journal now offers free open access for all individuals that subscribe to the journal, giving subscribers 24/7 access to online content from 1999 to present. The NZMJ is fully available to individual subscribers and does not incur a subscription fee.